Clinical Trial Update: Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Georgiamune Inc. is conducting a Phase 1/2 safety and tolerability trial of GIM-531 in patients with advanced solid tumors, including stage IV melanoma, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• GIM-531

Snippet

Sponsor: Georgiamune Inc | Conditions: Melanoma Stage IV, Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING